Clinical Trial Update: Cabergoline in Nonfunctioning Pituitary Adenomas [Phase 3]

View source ↗

Summary

A Phase 3 trial update for cabergoline in nonfunctioning pituitary adenomas has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonfunctioning Pituitary Adenoma
• Pituitary Adenoma

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Pituitary Adenoma, Nonfunctioning Pituitary Adenoma | Phase 3 | Status: COMPLETED